EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021

O Lindner iD, M Hacker iD, W Burchert, R R Buechel iD

European Journal of Nuclear Medicine and Molecular Imaging · 2023-10 · 50 (12) · 3602-3608

DOI: 10.1007/s00259-023-06336-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 15.07.2023. Verfasst von O Lindner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Georgstr. 11, Bad Oeynhausen, Germany. olindner@hdz…. Hauptthemen laut MEDLINE: Myocardial Perfusion Imaging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heart and Diabetes Centre North Rhine-Westphalia (DKZ NRW).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This paper presents the results of the first joint survey on the use of SPECT and PET myocardial perfusion imaging (MPI) and cardiac amyloidosis imaging in Austria, Germany, and Switzerland of the year 2021.

Methods

A questionnaire was sent in 2022 to centres practicing nuclear medicine.

Results

Data from 14 Austrian (10,710 SPECT), 218 German (133,047 SPECT), and 16 Swiss centres (11,601 MPI (6,879 SPECT, 4722 PET)) were analysed. In Austria and Germany, the PET MPI numbers were close to zero and not considered. Official MPS numbers from 2015 to 2021 from Austria and Germany revealed a decline in Austria by about 40% in the pandemic years 2020 to 2021, but an increase in Germany by 9%. Ambulatory care cardiologists represented the major referral group (56–71%). Mostly, stress tests were performed pharmacologically (58–92%). Contrary to Germany, a 1-day protocol was predominant (58–97%) in Austria and Switzerland. The leading camera systems were SPECT-CT in Austria and Switzerland (57–79%) and multi-head systems in Germany (58%). Switzerland had the highest proportion of SPECT MPI with attenuation correction (84%), followed by Austria (43%), and Germany (33%). Electrocardiogram-gated SPECT MPI showed an overall high penetration of 87–99%. Scoring was most frequently applied in Germany (72%), followed by Austria (64%), and Switzerland (60%). Related to the population, the number of cardiac amyloidosis imaging was highest in Austria, followed by Switzerland and Germany.

Conclusions

This first joint survey of 2021 shows considerable differences among the countries. The Swiss situation is outstanding due to the wide use of PET MPI. In terms of camera equipment, Switzerland is also leading, followed by Austria and Germany. Despite the differences in procedural issues, the results reveal an overall high standard of MPI imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Perfusion ImagingHumansSwitzerlandAustriaTomography, Emission-Computed, Single-PhotonSurveys and QuestionnairesGermany

Stichwörter der Autor:innen

Amyloidosis imagingMyocardial perfusion scintigraphyNumerical dataUtilisation reviewUtilisation statistics

Autor:innen und Institutionen

  • Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Georgstr. 11, Bad Oeynhausen, Germany. olindner@hdz-nrw.de.
  • Klinische Abteilung für Nuklearmedizin, Universitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien, Vienna, Austria.
  • Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Georgstr. 11, Bad Oeynhausen, Germany.
  • Klinik für Nuklearmedizin, Universitätsspital Zürich, Zurich, Switzerland.

ORCID-Profile: O Lindner, M Hacker, R R Buechel

Förderung

  • Heart and Diabetes Centre North Rhine-Westphalia (DKZ NRW)

Zitieren

APA

Lindner, O., Hacker, M., Burchert, W., & Buechel, R. R. (2023). SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021. European Journal of Nuclear Medicine and Molecular Imaging, 50(12), 3602-3608. https://doi.org/10.1007/s00259-023-06336-8

Vancouver

Lindner O, Hacker M, Burchert W, Buechel RR. SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021. European Journal of Nuclear Medicine and Molecular Imaging. 2023;50(12):3602-3608. doi:10.1007/s00259-023-06336-8

BibTeX
@article{Lindner2023,
  author = {Lindner, O and Hacker, M and Burchert, W and Buechel, R R},
  title = {SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  volume = {50},
  number = {12},
  pages = {3602--3608},
  doi = {10.1007/s00259-023-06336-8}
}
Kostenlos starten →